Insulin pill may mean end to daily shots

Jun 22, 2007

A British company has developed an insulin pill that may provide better control of diabetes symptoms than daily insulin injections.

The company Diabetology said it has found a way to enclose the insulin in a capsule that resists stomach acids and passes intact into the small intestine, where it dissolves. The insulin is then transported to the liver, where the body uses it as needed, The Times of London said Friday.

A Cardiff University team found that an oral dose taken before breakfast and before dinner controlled glucose levels successfully in 16 patients with type 2 diabetes.

The newspaper said the insulin pill more closely approximates the behavior of the pancreas, which is the source of insulin in people who don't have diabetes.

The findings were to be presented at the American Diabetes Association meeting in Chicago.

Copyright 2007 by United Press International

Explore further: Acne pill benefits outweigh blood clot risk: EU agency

add to favorites email to friend print save as pdf

Related Stories

IT industry ignores silver surfers at its peril

40 minutes ago

Hardware and software vendors are foolish to ignore the needs of the growing population of older computer and information technology users, the so-called "silver surfers". US researchers offer convincing evidence in a monograph ...

Playing at pirate games: Busting a few digital piracy myths

42 minutes ago

The results of a large-scale, analysis of BitTorrent file-sharing of computer games, focusing on using open methodologies are to be published in the International Journal of Advanced Media and Communication and bust some o ...

Water governs cell movement

44 minutes ago

Water gives life. Researchers at Linköping University in Sweden now show how the cells in our bodies are driven mainly by water power – a discovery that in the long run opens the way for a new strategy ...

Recommended for you

First influenza vaccine brought to clinical testing

May 17, 2013

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...

Aspirin not always best treatment for many individuals

May 16, 2013

(Medical Xpress)—An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as ...

FDA: lower ambien's dose to prevent drowsy driving

May 15, 2013

(HealthDay)—The U.S. Food and Drug Administration has approved new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) in an effort to cut down on daytime drowsiness that could be a hazard ...

Simponi approved for ulcerative colitis

May 15, 2013

(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.

FDA approves genetic test for lung cancer drug

May 14, 2013

The Food and Drug Administration says it approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by Genentech.

User comments : 0

More news stories

Morocco to harness the wind in energy hunt

Morocco is ploughing ahead with a programme to boost wind energy production, particularly in the southern Tarfaya region, where Africa's largest wind farm is set to open in 2014.

Galaxy's Ring of Fire

Johnny Cash may have preferred this galaxy's burning ring of fire to the one he sang about falling into in his popular song. The "starburst ring" seen at center in red and yellow hues is not the product of ...